Actavis Chairman Offers $4.5 Billion for Drug Company
STOCKHOLM/LONDON, May 10 (Reuters) - Iceland's Actavis (ACT.IC: Quote, Profile , Research) said an investment firm led by its own chairman planned to make a $4.5 billion bid for the generic drugmaker, sending its shares sharply higher on Thursday.